Nutex Health (NUTX) Gains from Investment Securities (2012 - 2026)

Nutex Health has disclosed Gains from Investment Securities across 12 years of filings, most recently posting $1.6 million for Q1 2026.

• Gains from Investment Securities for Q1 2026 came in at $1.6 million, up 13.61% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.4 million (up 8.02% YoY), and the FY2025 annual result was $5.2 million, up 13.31% from the prior year.
• Gains from Investment Securities came in at $1.6 million for Q1 2026 at Nutex Health, up from $1.2 million in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $6.2 million in Q2 2022 to a low of $472000.0 in Q2 2024.
• The 4-year median for Gains from Investment Securities is $1.3 million (2025), against an average of $2.1 million.
• Across the five-year window, Gains from Investment Securities jumped 4168.1% in 2022 and sank 54.14% in 2025, its largest moves.
• Nutex Health's Gains from Investment Securities stood at $1.0 million in 2022, then surged by 159.94% to $2.7 million in 2024, then tumbled by 54.14% to $1.2 million in 2025, then grew by 25.24% to $1.6 million in 2026.
• The last three Gains from Investment Securities figures came in at $1.6 million (Q1 2026), $1.2 million (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.